Dade Behring sees win-win scenario in free consulting for customers
This article was originally published in Clinica
Dade Behring sets great store by its ability to understand and respond to its customers' needs. And by offering consulting services to the labs it does business with, it believes it increases value for customers at the same time as improving its own business prospects. Company spokesperson Connie DuBois spoke to Clinica's Eleanor Malone
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.